Abeona Therapeutics Inc vs Arqit Quantum Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Arqit Quantum Inc trades at $24.47 (market cap $424.79M). The key difference: Abeona Therapeutics Inc and Arqit Quantum Inc are close in size by market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Arqit Quantum Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | ARQQ | |
|---|---|---|
Market Cap | $421.19M | $424.79M |
Sector | Health | Technology |
52-Week High | $7.45 | $58.27 |
52-Week Low | $4.17 | $11.78 |
Enterprise Value | $276.10M | $398.10M |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →Arqit Quantum provides advanced cybersecurity software that uses symmetric key agreement technology. Its solutions protect networked devices and data against current and future cyber threats, including quantum attacks.
Read more on ARQQ →